BioGaia Sets May 7 AGM to Vote on Board Slate and New Performance Share Plan

The latest update is out from BioGaia AB ( ($SE:BIOG.B) ).

BioGaia AB has convened its Annual General Meeting for 7 May 2026 in central Stockholm, setting out participation rules for shareholders, including registration deadlines and procedures for nominee-registered holdings and proxy representation. The agenda covers standard governance items such as approval of financial statements, discharge of liability for directors and the CEO, and decisions on board and auditor composition and remuneration.

Shareholders will vote on the re-election of five current board members and the appointment of a new director, Amy Byrick, as well as the selection of the board chair and vice chair, signaling potential continuity with a slight refresh in board expertise. The meeting will also decide on a new Employee Performance Share Plan for 2026–2029 involving a directed issue of warrants, a move that could align management incentives with long-term shareholder value and influence the company’s capital structure and talent retention strategy.

The most recent analyst rating on ($SE:BIOG.B) stock is a Hold with a SEK126.00 price target. To see the full list of analyst forecasts on BioGaia AB stock, see the SE:BIOG.B Stock Forecast page.

More about BioGaia AB

BioGaia AB is a Swedish public company operating in the health and nutrition sector, focusing on probiotic products for gut health and related medical applications. The company targets both consumer and professional healthcare markets with clinically tested probiotic solutions, positioning itself within the global functional foods and dietary supplements industry.

YTD Price Performance: 10.26%

Average Trading Volume: 273,517

Technical Sentiment Signal: Strong Buy

Current Market Cap: SEK11.97B

See more data about BIOG.B stock on TipRanks’ Stock Analysis page.